Compare companies
| Amgen | Gilead Sciences | ABIOMED | ||||
|---|---|---|---|---|---|---|
| Capitalization | ||||||
| Price | 306.86 | 107.89 | 381.02 | |||
| Price priv. | ||||||
| Number of shares, million | 538 | 1258 | 45.88 | |||
| Capitalization, billion | 140.05 | 94.55 | 17.18 | |||
| EBITDA, billion | 7.9 | 7.61 | 0.2685 | |||
| EV, billion | 206.55 | 119.11 | 14.63 | |||
| Profit and loss report | ||||||
| Net profit, billion | 6.72 | 5.67 | 0.1365 | |||
| Revenue, billion | 28.19 | 27.12 | 1.03 | |||
| EPS | 12.49 | 4.5 | 2.98 | |||
| Balance | ||||||
| Assets, billion | 97.15 | 62.13 | 1.67 | |||
| Debt, billion | 64.61 | 24.99 | 0.01 | |||
| Balance cost, billion | 6.23 | 22.75 | 1.5 | |||
| Cash, billion | 10.94 | 6.09 | 0.1328 | |||
| Coefficients | ||||||
| Dividend yield, % | 2.92 | 3.69 | 0 | |||
| Dividend | 9.13 | 3.87 | 0 | |||
| Dividend yield priv., % | 0 | 0 | 0 | |||
| Dividend priv. | 0 | 0 | 0 | |||
| Dividends/profit, % | 67.83 | 67.24 | 0 | |||
| P/S | 5.42 | 3.7 | 14.31 | |||
| P/BV | 24.53 | 4.41 | 9.82 | |||
| P/E | 22.76 | 17.69 | 108.16 | |||
| Ev/Ebitda | 26.16 | 15.66 | 54.5 | |||
| Debt/Ebitda | 8.18 | 3.29 | 0.0372 | |||
| Efficiency | ||||||
| ROE | 107.78 | 24.9 | 9.64 | |||
| ROA | 6.91 | 9.12 | 8.62 | |||
| ROIC | 17 | 11.06 | 7.12 | |||
| Ebitda margin | 28.01 | 28.05 | 26.02 | |||
| Net margin | 23.83 | 20.89 | 13.23 | |||
| Momentum | ||||||
| 1 week, price changes | -2.82 % | +0.3535 % | 0 % | |||
| 1 month, price changes | -0.9234 % | -2.83 % | 0 % | |||
| 3 months, price changes | +16.02 % | +14.84 % | 0 % | |||
| 6 months, price changes | -3.84 % | +29.93 % | 0 % | |||
| 1 year, price changes | +7.18 % | +47.77 % | 0 % | |||
| 3 years, price changes | +31.59 % | +81.82 % | +28.8 % | |||
| 5 years, price changes | +33.46 % | +80.42 % | +44.35 % | |||
| 10 years, price changes | +101.52 % | +24.66 % | +287.93 % | |||
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
